🇺🇸 FDA
Company

Tvardi

Tvardi Therapeutics

TVRD pharma USA

Quick answer

Tvardi is a pharma company (TVRD) headquartered in SUGAR LAND, TX, USA with 6 tracked pipeline programs.

Pipeline (6)

project

TTI-101

Head and Neck Squamous Cell Carcinoma

Phase 2 · small_molecule · terminated

1 trials project

TTI-101

Hepatocellular Carcinoma

Phase 2 · small_molecule · active

1 trials project

TTI-101

Idiopathic Pulmonary Fibrosis

Phase 2 · small_molecule · completed

1 trials project

Control Group

Squamous Cell Carcinoma of Head and Neck

Phase 1 · small_molecule · terminated

1 trials project

TTI-101

Breast Cancer

Phase 1 · small_molecule · completed

2 trials project

TTI-101

Pancreatic Cancer

Phase 1 · small_molecule · active

1 trials

Patents (6)

patent

US 12053444

Therapeutic compounds, formulations, and uses thereof

Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12043640

Prodrugs of STAT3 inhibitors

Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11826315

STAT3 inhibitors

Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11547683

Therapeutic compounds, formulations, and uses thereof

Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11077077

Therapeutic compounds, formulations, and uses thereof

Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11026905

STAT3 inhibitors

Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)